Drug Type Fusion protein |
Synonyms |
Target |
Mechanism p75NTR antagonists(Low affinity neurotrophin receptor p75NTR antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ankylosing Spondylitis | Preclinical | CN | 24 May 2024 | |
Plaque psoriasis | Preclinical | CN | 24 May 2024 | |
Rheumatoid Arthritis | Preclinical | CN | 24 May 2024 |